ClinicalTrials.Veeva

Menu

European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis (ERGOSTE)

A

Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)

Status

Invitation-only

Conditions

Infective Endocarditis (IE)

Study type

Observational

Funder types

Other

Identifiers

NCT07108803
386_2024

Details and patient eligibility

About

The European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis (ERGOSTE) is a nascent large surgical registry that would encompass most relevant aspects of IE in Europe in the contemporary era.

Full description

ERGOSTE, Purposes:

  • To create a European multicenter retrospective database including a large number of patients undergoing surgical treatment for infective endocarditis (IE).
  • To perform epidemiologic analyses of IE-patients and involved pathogens.
  • To find independent predictors of early post-operative death.
  • To test ALL the scoring systems specifically developed to predict early death after surgery for infective endocarditis.
  • To devise a specific risk score for early postoperative death.
  • To explore early and late outcomes of these very difficult patients in order to establish optimal indications, techniques and timing of surgery.
  • To carry out a number of sub-analyses concerning the demographic parameters and variable clinical presentation of patients, type and severity of cardiac structural involvement, adopted valve prostheses and surgical techniques, and different involved microbiologic agents.
  • To lay experiential foundations of a prospective database on the topic.

Enrollment

2,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing cardiac surgery due to infective endocarditis

Exclusion criteria

  • Patients under 18 years

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems